Talk:Sinclair method
 | This redirect does not require a rating on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||
| ||||||||
 | The contents of the Sinclair method page were merged into Alcoholism#Medications. For the contribution history and old versions of the merged article please see its history. |
Failed AfD
[edit]The old Sinclair Method article was deleted as per Wikipedia:Articles_for_deletion/Sinclair_Method_(2nd_nomination) Defendingaa (talk) 07:24, 28 May 2018 (UTC)
unsourced
[edit]moved here per PRESERVE
- History
Research into the causes of and possible solutions for alcohol use disorder began in the mid 1960s. It was funded through an Act Of Parliament to reduce the harm caused by excessive drinking. In 1969, the government owned Alko Labs - currently the National Public Health and Welfare Institute, Helsinki - recruited Dr. David Sinclair from the University of Oregon after his publications on the Alcohol Deprivation Effect[1] with the first human trials using naltrexone and nalmefene starting in the mid 1990s.
References
- ^ Koros, Eliza; Piasecki, Jerzy; Kostowski, Wojciech; Bienkowski, Przemyslaw (1999-07-01). "Development of Alcohol Deprivation Effect in Rats: Lack of Correlation with Saccharin Drinking and Locomotor Activity". Alcohol and Alcoholism. 34 (4): 542–550. doi:10.1093/alcalc/34.4.542. ISSN 0735-0414. PMID 10456582.